ArticleThe oncologist2018

Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma.

Mahdi Zargar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.